Brokerages Set Doximity, Inc. (NASDAQ:DOCS) PT at $66.21

Doximity, Inc. (NASDAQ:DOCS) has been assigned an average recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the company, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $66.2105.

Several research analysts recently commented on the company. William Blair reissued an “outperform” rating on shares of Doximity in a research note on Friday, May 16th. Mizuho lowered their price objective on Doximity from $65.00 to $60.00 and set a “neutral” rating for the company in a research report on Friday, May 16th. Wells Fargo & Company upped their price objective on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Monday, August 4th. KeyCorp upped their price objective on Doximity from $65.00 to $70.00 and gave the stock an “overweight” rating in a research report on Monday, July 14th. Finally, Piper Sandler upped their price objective on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th.

Doximity Price Performance

DOCS opened at $69.55 on Wednesday. Doximity has a 12 month low of $36.12 and a 12 month high of $85.21. The stock has a market capitalization of $13.03 billion, a price-to-earnings ratio of 69.55, a PEG ratio of 4.10 and a beta of 1.37. The business has a fifty day moving average price of $63.05 and a 200 day moving average price of $59.88.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the previous year, the business posted $0.28 earnings per share. Doximity’s revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts anticipate that Doximity will post 0.99 earnings per share for the current year.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 10,000 shares of the business’s stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the completion of the sale, the director directly owned 6,360 shares of the company’s stock, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director directly owned 16,618 shares of the company’s stock, valued at $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,000 shares of company stock valued at $1,929,380. 31.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Doximity

Institutional investors and hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in Doximity during the 1st quarter valued at approximately $65,702,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock valued at $114,133,000 after acquiring an additional 1,113,076 shares during the last quarter. Franklin Resources Inc. raised its stake in Doximity by 53.9% during the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after acquiring an additional 1,108,162 shares during the last quarter. Vanguard Group Inc. raised its stake in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after acquiring an additional 990,923 shares during the last quarter. Finally, Holocene Advisors LP purchased a new stake in Doximity during the 2nd quarter valued at approximately $44,983,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.